Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury

Abstract Despite being relatively rare, anti-tuberculosis drug-induced liver injury (ATDILI) is a leading cause of acute liver failure and a major reason for treatment discontinuation, because of no specific and selective markers for ATDILI. Herein, this study aimed to investigate whether telomere l...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wanvisa Udomsinprasert, Noppadol Chanhom, Supharat Suvichapanich, Sukanya Wattanapokayakit, Surakameth Mahasirimongkol, Wasun Chantratita, Jiraphun Jittikoon
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/b5121869f25147ef9bef159e048baf9a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b5121869f25147ef9bef159e048baf9a
record_format	dspace
spelling	oai:doaj.org-article:b5121869f25147ef9bef159e048baf9a2021-12-02T17:04:37ZLeukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury10.1038/s41598-020-62635-22045-2322https://doaj.org/article/b5121869f25147ef9bef159e048baf9a2020-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-62635-2https://doaj.org/toc/2045-2322Abstract Despite being relatively rare, anti-tuberculosis drug-induced liver injury (ATDILI) is a leading cause of acute liver failure and a major reason for treatment discontinuation, because of no specific and selective markers for ATDILI. Herein, this study aimed to investigate whether telomere length, a biological indicator of age-related diseases, is associated with ATDILI outcomes and could serve as an early ATDILI biomarker. Relative telomere length (RTL) in blood leukocyte of 100 age- and gender-matched healthy controls, 49 tuberculosis patients with ATDILI, and 53 tuberculosis patients with non-ATDILI was quantified using real-time polymerase chain reaction. Both tuberculosis patients with and without ATDILI had significantly shorter RTL than healthy controls. Compared with tuberculosis patients with non-ATDILI, RTL in those with ATDILI was significantly increased. Longer RTL was found to be significantly associated with increased susceptibility to ATDILI. Multivariate linear regression analysis showed that an increment in RTL was independently correlated with elevated values of aspartate aminotransferase and alanine aminotransferase assessed within 60 days after anti-tuberculosis treatment. Kaplan-Meier curve analysis demonstrated that longer RTL was associated with elevated rates of hepatotoxicity in tuberculosis patients. Receiver-operating characteristic curve analysis unveiled a diagnostic accuracy of RTL as a novel indicator for ATDILI progression (AUC = 0.73), which yielded more sensitive and specific values than traditional liver biomarkers including serum enzyme activities of aminotransferases measured within 7 days after treatment with anti-tuberculosis regimens. Collectively, aberrant RTL in blood leukocyte would reflect hepatotoxicity induced by anti-tuberculosis agents and might have a potential biomarker for early ATDILI progression.Wanvisa UdomsinprasertNoppadol ChanhomSupharat SuvichapanichSukanya WattanapokayakitSurakameth MahasirimongkolWasun ChantratitaJiraphun JittikoonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Wanvisa Udomsinprasert Noppadol Chanhom Supharat Suvichapanich Sukanya Wattanapokayakit Surakameth Mahasirimongkol Wasun Chantratita Jiraphun Jittikoon Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
description	Abstract Despite being relatively rare, anti-tuberculosis drug-induced liver injury (ATDILI) is a leading cause of acute liver failure and a major reason for treatment discontinuation, because of no specific and selective markers for ATDILI. Herein, this study aimed to investigate whether telomere length, a biological indicator of age-related diseases, is associated with ATDILI outcomes and could serve as an early ATDILI biomarker. Relative telomere length (RTL) in blood leukocyte of 100 age- and gender-matched healthy controls, 49 tuberculosis patients with ATDILI, and 53 tuberculosis patients with non-ATDILI was quantified using real-time polymerase chain reaction. Both tuberculosis patients with and without ATDILI had significantly shorter RTL than healthy controls. Compared with tuberculosis patients with non-ATDILI, RTL in those with ATDILI was significantly increased. Longer RTL was found to be significantly associated with increased susceptibility to ATDILI. Multivariate linear regression analysis showed that an increment in RTL was independently correlated with elevated values of aspartate aminotransferase and alanine aminotransferase assessed within 60 days after anti-tuberculosis treatment. Kaplan-Meier curve analysis demonstrated that longer RTL was associated with elevated rates of hepatotoxicity in tuberculosis patients. Receiver-operating characteristic curve analysis unveiled a diagnostic accuracy of RTL as a novel indicator for ATDILI progression (AUC = 0.73), which yielded more sensitive and specific values than traditional liver biomarkers including serum enzyme activities of aminotransferases measured within 7 days after treatment with anti-tuberculosis regimens. Collectively, aberrant RTL in blood leukocyte would reflect hepatotoxicity induced by anti-tuberculosis agents and might have a potential biomarker for early ATDILI progression.
format	article
author	Wanvisa Udomsinprasert Noppadol Chanhom Supharat Suvichapanich Sukanya Wattanapokayakit Surakameth Mahasirimongkol Wasun Chantratita Jiraphun Jittikoon
author_facet	Wanvisa Udomsinprasert Noppadol Chanhom Supharat Suvichapanich Sukanya Wattanapokayakit Surakameth Mahasirimongkol Wasun Chantratita Jiraphun Jittikoon
author_sort	Wanvisa Udomsinprasert
title	Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
title_short	Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
title_full	Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
title_fullStr	Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
title_full_unstemmed	Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
title_sort	leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/b5121869f25147ef9bef159e048baf9a
work_keys_str_mv	AT wanvisaudomsinprasert leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury AT noppadolchanhom leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury AT supharatsuvichapanich leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury AT sukanyawattanapokayakit leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury AT surakamethmahasirimongkol leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury AT wasunchantratita leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury AT jiraphunjittikoon leukocytetelomerelengthasadiagnosticbiomarkerforantituberculosisdruginducedliverinjury
_version_	1718381870199078912

Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury

Ejemplares similares